Hyperbaric Oxygen Therapy (HBOT)

Hyperbaric oxygen therapy at Dallas Longevity Center delivers 100% oxygen at 1.5–2.0 atmospheres of pressure, driving elevated oxygen saturation into plasma, tissues, and the central nervous system. Sessions support cellular repair, reduce systemic inflammation, accelerate recovery, and are increasingly used in longevity protocols for cognitive and mitochondrial health. Available as standalone sessions or integrated into multi-week longevity programs with biomarker monitoring.

Hyperbaric oxygen therapy (HBOT) at Dallas Longevity Center operates monoplace chambers that deliver 100% oxygen at pressures between 1.5 and 2.0 atmospheres absolute (ATA). At this elevated partial pressure, oxygen dissolves directly into plasma — independently of red blood cell hemoglobin — achieving tissue oxygen concentrations that normal breathing at sea level cannot reach. The physiological effects are broad: HBOT drives angiogenesis (new blood vessel formation), stimulates stem cell mobilization from bone marrow, reduces pro-inflammatory cytokine expression, and activates cellular repair pathways including mitochondrial biogenesis. The longevity application of HBOT has been boosted by research published in the journal Aging (2020), which showed that a structured 60-session HBOT protocol produced significant increases in telomere length and a reduction in senescent cell load in a cohort of healthy aging adults — two biomarkers directly relevant to biological aging rate. Dallas Longevity Center incorporates this protocol framework into its multi-week longevity programs, typically recommending 40–60 sessions for patients pursuing anti-aging applications, with biomarker testing before and after the protocol to measure biological response. For patients with more immediate clinical goals — post-surgical recovery, wound healing support, sports injury, or cognitive fog — single sessions and 10-session packages provide a more targeted entry point. Each session lasts approximately 60 minutes inside the chamber; patients typically read, rest, or listen to audio during the session. The experience is non-claustrophobic for most patients in the monoplace design, and trained staff are in visual contact throughout. Common presentations at the Dallas Longevity Center HBOT program include post-COVID cognitive recovery, traumatic brain injury sequelae, athletic performance recovery, and longevity protocol integration. Contraindications including active pneumothorax, untreated claustrophobia, and certain medications are screened at intake.